ASKA PHARMACEUTICAL CO., LTD. Inactive Instrument
Calendar ASKA Pharmaceutical Co., Ltd. Japan Exchange
Equities
4514
JP3541200006
Chart calendar ASKA Pharmaceutical Co., Ltd.
e0632abafb4f926a6f9a232e966a85e8.X4H7FnJWLvMrVKiEsxi5XveMsBJw6R3i7yYr4Okkx_U.Ds-kfgs-HcFDHubX4XXuAcD40lAXq1KKik5Ch4JG9ZsKtcJxMGJAlHgS-Q~7a7f7265be1341e6a04bf478aa9828c0
Upcoming events on ASKA Pharmaceutical Co., Ltd.
Past events on ASKA Pharmaceutical Co., Ltd.
| 2024-02-04 | Q3 2023 Earnings Release |
| 2023-11-05 | Q2 2023 Earnings Release |
| 2023-08-06 | Q1 2023 Earnings Release |
| 2023-05-10 | Q4 2022 Earnings Release |
| 2023-02-05 | Q3 2022 Earnings Release |
| 2022-11-06 | Interim 2022 Earnings Release |
| 2022-08-07 | Q1 2022 Earnings Release |
| 2022-05-11 | FY 2021 Earnings Release |
| 2022-02-06 | Q3 2022 Earnings Release |
| 2021-10-31 | Interim 2021 Earnings Release |
| 2021-08-01 | Q1 2021 Earnings Release |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 46 706 48 500 -3.7% | 52 542 52 500 0.08% | 55 181 55 100 0.15% | 56 607 57 000 -0.69% | 60 461 60 300 0.27% | 63 285 |
|
EBITDA Million JPY | Released Forecast Spread | 4 273 4 400 -2.89% | 5 268 5 300 -0.6% | 6 915 6 999 -1.2% | 13 633 14 600 -6.62% | 8 235 8 590 -4.13% | 8 984 |
|
EBIT Million JPY | Released Forecast Spread | 1 782 2 100 -15.14% | 1 507 1 500 0.47% | 3 609 3 600 0.25% | 4 795 4 500 6.56% | 5 108 5 300 -3.62% | 5 688 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 883 1 950 -3.44% | 901 1 000 -9.9% | 3 575 3 300 8.33% | 6 163 5 600 10.05% | 5 357 5 450 -1.71% | 8 571 |
|
Net income Million JPY | Released Forecast Spread | 1 744 1 650 5.7% | 649 600 8.17% | 2 713 2 700 0.48% | 4 290 4 000 7.25% | 4 238 4 250 -0.28% | 6 466 |
|
EPS JPY | Released Forecast Spread | 61,8 58,4 5.84% | 23,0 21,2 8.3% | 95,7 95,2 0.55% | 151 141 7.4% | 150 150 -0.15% | 228 |
| Announcement Date | 10/05/19 | 12/05/20 | 11/05/21 | 12/05/22 | 11/05/23 | - |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 26 582 27 300 -2.63% | 27 403 27 100 1.12% | 28 477 27 310 4.27% | 15 702 15 123 3.83% | 12 428 12 821 -3.07% | 15 269 14 750 3.52% | 14 903 14 631 1.86% | 30 172 29 900 0.91% | 17 087 16 828 1.54% | 13 202 13 041 1.23% | 16 023 | 15 625 15 677 -0.33% | 31 648 31 700 -0.16% | 17 176 17 430 -1.46% | 14 176 | 16 149 | 32 783 |
|
EBIT Million JPY | Released Forecast Spread | 746 1 600 -53.38% | 1 946 1 040 87.12% | 2 657 1 700 56.29% | 2 020 1 343 50.41% | 118 -177 166.67% | 1 664 1 050 58.48% | 1 215 1 036 17.28% | 2 879 2 700 6.63% | 2 162 2 171 -0.41% | 67,0 259 -74.13% | 1 704 | 1 351 1 506 -10.29% | 3 055 3 210 -4.83% | 2 471 2 300 7.43% | 74,0 | 1 695 | 3 454 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 918 | 1 952 990 97.17% | -4 139 | 9 988 | 1 805 | 1 214 945 28.47% | 3 019 2 750 9.78% | 2 348 2 163 8.55% | 1 873 | 5 410 | 3 110 | ||||||
|
Net income Million JPY | Released Forecast Spread | 577 1 000 -42.3% | 1 552 780 98.97% | -2 796 -4 000 30.1% | 6 878 596 1054.03% | 208 -82,0 353.66% | 1 323 | 1 023 795 28.68% | 2 346 2 118 10.76% | 1 837 1 723 6.62% | 55,0 67,0 -17.91% | 1 428 | 2 701 2 372 13.87% | 4 129 3 800 8.66% | 2 329 2 400 -2.96% | -108 | 1 292 | 2 633 |
|
EPS JPY | Released Forecast Spread | 20,4 | 54,8 | -98,5 | 242 | 46,9 | 83,2 | 65,0 | 50,5 | 146 | 82,2 | 43,8 | 89,5 | |||||
| Announcement Date | 05/11/19 | 04/11/20 | 01/11/21 | 07/02/22 | 12/05/22 | 08/08/22 | 07/11/22 | 07/11/22 | 06/02/23 | 11/05/23 | 07/08/23 | 06/11/23 | 06/11/23 | 05/02/24 | - | - | - |
More events